WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 1-December 2016 (data as of 18-November-2016)
Next overall update June 2017
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 362
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 462

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 53'897  53'437  52'984  52'544  52'125  47'670  42'007  34'471 
Births 944  951  961  976  994  1'158  1'131  1'240 
Surviving infants 902  908  917  930  946  1'087  1'044  1'122 
Pop. less than 5 years 4'565  4'624  4'695  4'783  4'901  5'203  5'294  5'288 
Pop. less than 15 years 14'849  14'993  15'114  15'215  15'310  15'214  15'806  14'166 
Female 15-49 years 14'772  14'640  14'515  14'398  14'287  13'416  10'659  8'133 

Number of reported cases

(Click for retrospective incidence data for Myanmar)
Diphtheria
ChartChart
  87  29  38  19  17  181  830 
Japanese encephalitis
ChartChart
  113  50  14  20 
Measles
ChartChart ChartChart
  122  1'010  2'175  2'046  845  7'900  21'457 
Mumps
ChartChart
 
Pertussis
ChartChart
  14  55  7'882  26'878 
Polio*
ChartChart
  44  47  244 
Rubella
ChartChart
  34  30  23  21  103 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  30  32  39  29  32  41  27  124 
Tetanus (total)**
ChartChart
  73  73  75  178  312  769  2'423 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Myanmar)
Vaccine year result method % card seen                                                
BCG 2008  98  MICS   96  94  92  86  87  93  88  67 
DTP1 2008  98  MICS   96  94  92  90  89  88  87 
DTP3 2008  98  MICS   96  89  88  75  84  86  82  69 
DTP4         
IPV1          93 
HepB_BD         
HepB3 2008  98  MICS   96  89  88  72  38 
Hib3          89  88  72 
JapEnc         
MCV1          84  88  86  84  88  84  68 
MCV2          78  82  80  80 
PCV1         
PCV3         
Pol3 2008  98  MICS   96  89  88  76  87  90  86  69 
Rota1         
RotaC         
RCV1          84 
TT2plus 1999  78  MICS   52  83  85  81  85  87  81  56 
PAB         
VAD1          95  95  95  95 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Myanmar)
BCG
ChartChart
  86  86  86  87  93  88  95 
DTP1
ChartChart
  90  90  90  89  88  87  96  22 
DTP3
ChartChart
  75  75  75  84  84  82  88 
HepB3
ChartChart
  75  75  75  58  40 
HepB_BD
ChartChart
 
Hib3
ChartChart
  75  75  75 
IPV1
ChartChart
 
MCV1
ChartChart
  86  86  86  84  88  84  68 
MCV2
ChartChart
  80  80  80  80 
PAB
ChartChart
  87  87  87  93  93  79  62 
PCV3
ChartChart
 
Pol3
ChartChart
  76  76  76  87  90  88  88 
RCV1
ChartChart
  86 
RotaC
ChartChart
 

Number of districts in the country 330  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
96 
   
/
|
|
\
Greater or equal to 90% 66
From 80 to 89% 19
From 50 to 79% 7
Less than 50% 5
Proportion of districts
not reporting DTP3 coverage
3
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG Birth-2 months; Yes
DTwPHibHepB 2, 4, 6 months; Yes
IPV 4 months; Yes
MR 9 months; Yes
Measles 18 months; Yes
OPV 2, 4, 6 months; Yes
TT 1st contact pregnancy; +4 weeks; Yes
VitaminA 6-59, 13-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2017-2021  2012-2016  2012-2016    2012-2016  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 330  330  330  324  330  319  300 

System performance

Total Nº districts in country number 330  330  330  330  330  325  325 
Nº districts with DTP3 coverage >=80% number 282  273  147  214  252  284  289 
% of districts with DTP3 coverage >=80% From 0 to 100% 85  83  45  65  76  87  89 
Nº districts with measles (MCV1) coverage >=95% number 63  106  86  74  81  81  62 
% of districts with MCV1 coverage >=95% From 0 to 100% 19  32  26  22  25  25  19 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 31      23       

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Sources

 1  "The 2016 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.